A detailed history of Manufacturers Life Insurance Company, The transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 29,734 shares of AVXL stock, worth $221,518. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,734
Previous 30,510 2.54%
Holding current value
$221,518
Previous $128,000 31.25%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.11 - $7.04 $3,189 - $5,463
-776 Reduced 2.54%
29,734 $168,000
Q2 2024

Aug 14, 2024

BUY
$3.39 - $5.02 $8,139 - $12,053
2,401 Added 8.54%
30,510 $128,000
Q1 2024

May 14, 2024

BUY
$4.55 - $6.75 $4,408 - $6,540
969 Added 3.57%
28,109 $143,000
Q3 2023

Nov 15, 2023

BUY
$6.55 - $9.37 $602 - $862
92 Added 0.34%
27,140 $177,000
Q2 2023

Aug 11, 2023

BUY
$7.66 - $9.5 $11,512 - $14,278
1,503 Added 5.88%
27,048 $219,000
Q4 2022

Aug 11, 2023

SELL
$7.65 - $14.43 $512 - $966
-67 Reduced 0.26%
25,545 $236,000
Q4 2022

Feb 13, 2023

SELL
$7.65 - $14.43 $512 - $966
-67 Reduced 0.26%
25,545 $236,000
Q3 2022

Aug 11, 2023

SELL
$8.9 - $12.86 $5,393 - $7,793
-606 Reduced 2.31%
25,612 $264,000
Q3 2022

Nov 03, 2022

SELL
$8.9 - $12.86 $5,393 - $7,793
-606 Reduced 2.31%
25,612 $264,000
Q2 2022

Aug 11, 2023

BUY
$7.31 - $12.84 $4,349 - $7,639
595 Added 2.32%
26,218 $262,000
Q2 2022

Aug 15, 2022

BUY
$7.31 - $12.84 $4,349 - $7,639
595 Added 2.32%
26,218 $262,000
Q1 2022

Aug 11, 2023

BUY
$9.74 - $17.69 $759 - $1,379
78 Added 0.31%
25,623 $315,000
Q1 2022

May 20, 2022

BUY
$9.74 - $17.69 $249,568 - $453,270
25,623 New
25,623 $315,000
Q4 2021

Feb 16, 2022

SELL
$16.88 - $23.31 $536,935 - $741,467
-31,809 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$16.82 - $25.75 $38,803 - $59,405
-2,307 Reduced 6.76%
31,809 $571,000
Q2 2021

Aug 12, 2021

BUY
$10.16 - $28.86 $19,944 - $56,652
1,963 Added 6.11%
34,116 $780,000
Q1 2021

May 03, 2021

SELL
$5.17 - $16.13 $4,337 - $13,533
-839 Reduced 2.54%
32,153 $481,000
Q4 2020

Feb 12, 2021

BUY
$4.01 - $7.58 $7,073 - $13,371
1,764 Added 5.65%
32,992 $178,000
Q2 2020

Aug 10, 2020

BUY
$2.62 - $5.2 $1,506 - $2,990
575 Added 1.88%
31,228 $158,000
Q1 2020

May 15, 2020

BUY
$2.38 - $5.81 $6,554 - $16,000
2,754 Added 9.87%
30,653 $97,000
Q4 2019

Feb 14, 2020

SELL
$2.31 - $3.14 $4,077 - $5,542
-1,765 Reduced 5.95%
27,899 $72,000
Q2 2019

Aug 14, 2019

BUY
$2.75 - $3.7 $81,576 - $109,756
29,664 New
29,664 $100,000
Q1 2018

May 15, 2018

SELL
$2.32 - $3.44 $14,678 - $21,764
-6,327 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$3.12 - $4.94 $40,129 - $63,538
-12,862 Reduced 67.03%
6,327 $20,000
Q3 2017

Nov 14, 2017

BUY
$3.42 - $4.87 $65,626 - $93,450
19,189
19,189 $79,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $581M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.